Published in N Y State J Med on August 01, 1975
Body piercing medical concerns with cutting-edge fashion. J Gen Intern Med (1999) 1.11
A problem with ear piercing. Br Med J (1978) 1.09
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
HIV transmission through breastfeeding: a study in Malawi. JAMA (1999) 4.00
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med (1997) 2.81
High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51
Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35
Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28
The AIDS problem in Africa. Lancet (1986) 2.25
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ (1997) 2.03
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) (1985) 1.93
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Epstein-Barr virus RNA in Burkitt tumor tissue. Cell (1979) 1.88
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet (1985) 1.85
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82
Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ (1990) 1.81
Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis (1998) 1.79
Factors that could influence the spread of AIDS in Ghana, West Africa: knowledge of AIDS, sexual behavior, prostitution, and traditional medical practices. J Acquir Immune Defic Syndr (1991) 1.77
Interactions between persons at risk for AIDS and the general population in Denmark. Am J Epidemiol (1992) 1.76
Preventing AIDS now. BMJ (1991) 1.71
High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet (1994) 1.62
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
The clinical features of HIV infection in Africa. Br Med J (Clin Res Ed) (1986) 1.55
Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus. Lancet (1987) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control (2000) 1.50
Risk of suicide among persons with AIDS. A national assessment. JAMA (1992) 1.45
Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses (1987) 1.44
Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer (1978) 1.43
Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS (1998) 1.40
Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria/southeastern Siberia region. Proc Natl Acad Sci U S A (1994) 1.40
Search for HIV-1 group O infection in Nigeria. Lancet (1995) 1.38
Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol (1985) 1.37
Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ (1984) 1.36
Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Int J Epidemiol (1999) 1.34
Lymphocytic choriomeningitis outbreak associated with pet hamsters. Fifty-seven cases from New York State;. JAMA (1975) 1.32
Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol (1994) 1.29
Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr (2000) 1.28
Risk of AIDS after herpes zoster. Lancet (1987) 1.28
Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med (1987) 1.27
Severe illness associated with appearance of antibody to human immunodeficiency virus in an African. Br Med J (Clin Res Ed) (1986) 1.27
Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.26
Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) (1983) 1.26
Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer (1990) 1.25
Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer (1998) 1.25
Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis (1992) 1.22
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
Declining age at HIV infection in the United States. N Engl J Med (1994) 1.20
Lifestyle and antiviral antibody studies among homosexual men in Denmark. Acta Pathol Microbiol Immunol Scand B (1983) 1.20
A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex Transm Dis (1998) 1.20
Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis (1979) 1.19
Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS (2000) 1.18
Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer (2000) 1.17
Effect of knowledge of human immunodeficiency virus infection status on sexual activity among homosexual men. J Acquir Immune Defic Syndr (1990) 1.15
Changes in CD4+ and CD8+ cell levels during pregnancy and post partum in women seropositive and seronegative for human immunodeficiency virus-1. Am J Obstet Gynecol (1996) 1.11
Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. JAMA (1984) 1.10
Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol (1992) 1.10
High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs. Lancet (1984) 1.09
Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer (1978) 1.07
Lack of antibodies to HTLV-III/LAV in Danish dentists. JAMA (1986) 1.07
AIDS in Europe. Br Med J (Clin Res Ed) (1983) 1.06
An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings. J Med Virol (1990) 1.05
Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet (1999) 1.05
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa. Int J Cancer (1985) 1.04
Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J Natl Cancer Inst (1977) 1.03
Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol (1990) 1.03
Cancer trends in a population at risk of acquired immunodeficiency syndrome. J Natl Cancer Inst (1985) 1.02
Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer (1984) 1.02
Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int J Cancer (1993) 1.01
Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med (1985) 1.01
Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion. Am J Epidemiol (1997) 1.00
HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer (1998) 0.99
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. J Acquir Immune Defic Syndr (1991) 0.97
National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia? Ann Rheum Dis (2009) 0.97
Burkitt's lymphoma in Ghana: urban-rural distribution, time-space clustering and seasonality. Int J Cancer (1979) 0.97
Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.97
Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa. Lancet (1981) 0.97
HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results. Int J Cancer (1993) 0.96
Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol (1987) 0.96
Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr (1991) 0.96
Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer (1991) 0.95
Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. Int J Cancer (1991) 0.95
Lesser AIDS and tuberculosis. Lancet (1985) 0.94
Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res Hum Retroviruses (1993) 0.93
Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years. Pathobiology (1999) 0.93
Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients. Int J Cancer (1984) 0.92
The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer (1999) 0.91
Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet (1991) 0.91
Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group. J Infect Dis (1988) 0.91